The Valley Desk

Clinical trial reportNeuro-oncologyPublished

Long-term safety and efficacy of selumetinib in children with neurofibromatosis type 1 on a phase 1/2 trial for inoperable plexiform neurofibromas

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Children’s Hospital of Philadelphia. Affiliation source

Publication record

Type
Clinical trial report
Venue
Neuro-oncology
Published
Subject terms
Humans; Neurofibroma, Plexiform; Neurofibromatosis 1; Pain; Benzimidazoles; Child; Neurofibromatosis Type 1; Mek Inhibitors; Plexiform Neurofibromas
PubMed ID
37115514
PubMed Central ID
PMC10547508
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal